Announcements
- Teleflex Announces Quarterly Dividend
- Teleflex Reports First Quarter Financial Results and Full Year 2024 Outlook
- Teleflex Announces Multiple Clinical and Real-World Evidence Studies to Be Highlighted at the 2024 American Urological Association Annual Meeting
- Teleflex Announces the Limited Market Release of the Wattson™ Temporary Pacing Guidewire
- Teleflex to Present at the BofA Securities 2024 Health Care Conference
- Teleflex Announces First Quarter 2024 Earnings Conference Call Information
- Teleflex Incorporated Introduces the UroLift™ 2 System With Advanced Tissue Control, a Revolutionary Unified Platform Designed to Treat All Prostate Types
- Teleflex’s Climate Targets Validated by the Science Based Targets Initiative
- Teleflex Announces Quarterly Dividend
- Teleflex Reports Fourth Quarter and Full Year 2023 Financial Results
More ▼
Key statistics
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | -- |
Average volume | -- |
---|---|
Shares outstanding | 47.10m |
Free float | 46.98m |
P/E (TTM) | 32.45 |
Market cap | 9.56bn USD |
EPS (TTM) | 6.26 USD |
Annual div (ADY) | 23.21 MXN |
---|---|
Annual div yield (ADY) | -- |
Div ex-date | Feb 29 2024 |
Div pay-date | Mar 15 2024 |
Next div ex-date | May 14 2024 |
Next div pay-date | Jun 14 2024 |
Data delayed at least 20 minutes, as of Dec 30 1899.
More ▼